These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23293201)

  • 41. Covert hepatic encephalopathy: agreement and predictive validity of different indices.
    Montagnese S; Balistreri E; Schiff S; De Rui M; Angeli P; Zanus G; Cillo U; Bombonato G; Bolognesi M; Sacerdoti D; Gatta A; Merkel C; Amodio P
    World J Gastroenterol; 2014 Nov; 20(42):15756-62. PubMed ID: 25400460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bacterial DNA Translocation Is Associated With Overt Hepatic Encephalopathy and Mortality in Patients With Cirrhosis.
    Thanapirom K; Suksawatamnuay S; Wejnaruemarn S; Thaimai P; Siripon N; Ananchuensook P; Sriphoosanaphan S; Vanichanan J; Treeprasertsuk S; Poovorawan Y; Komolmit P
    Clin Transl Gastroenterol; 2024 May; 15(5):e00697. PubMed ID: 38488171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy.
    Duarte-Rojo A; Ruiz-Margáin A; Macias-Rodriguez RU; Cubero FJ; Estradas-Trujillo J; Muñoz-Fuentes RM; Torre A
    World J Gastroenterol; 2016 May; 22(17):4397-402. PubMed ID: 27158209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of EncephalApp Stroop Test in Cirrhotic Patients for Evaluating Covert Hepatic Encephalopathy.
    Kurniawan J; Ranty SS; Sulaiman AS; Gani RA
    Acta Med Indones; 2023 Jul; 55(3):296-306. PubMed ID: 37915156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis.
    Özel Coşkun BD; Özen M
    Turk J Gastroenterol; 2017 May; 28(3):191-196. PubMed ID: 28316320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum natremia affects health-related quality of life in patients with liver cirrhosis: a prospective, single centre study.
    Wunsch E; Naprawa G; Koziarska D; Milkiewicz M; Nowacki P; Milkiewicz P
    Ann Hepatol; 2013; 12(3):448-55. PubMed ID: 23619262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study.
    Weiss N; Tripon S; Lodey M; Guiller E; Junot H; Monneret D; Mayaux J; Brisson H; Mallet M; Rudler M; Imbert-Bismut F; Thabut D;
    Fundam Clin Pharmacol; 2018 Apr; 32(2):209-215. PubMed ID: 29239015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis.
    Luo M; Li L; Yang EN; Dai CY; Liang SR; Cao WK
    Clin Res Hepatol Gastroenterol; 2013 Sep; 37(4):384-90. PubMed ID: 23084463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
    Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
    Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arterial ammonia with Blood Ammonia Checker II and with indophenol reaction to assess presence of hepatic encephalopathy.
    Huizenga JR; van Dam GM; Gips CH
    Clin Chim Acta; 1996 Aug; 252(1):73-82. PubMed ID: 8814363
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy.
    Butz M; Timmermann L; Braun M; Groiss SJ; Wojtecki L; Ostrowski S; Krause H; Pollok B; Gross J; Südmeyer M; Kircheis G; Häussinger D; Schnitzler A
    Acta Neurol Scand; 2010 Jul; 122(1):27-35. PubMed ID: 20003084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure.
    Odeh M; Sabo E; Srugo I; Oliven A
    Ann Med; 2005; 37(8):603-12. PubMed ID: 16338762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors contributing to the development of overt encephalopathy in liver cirrhosis patients.
    Iwasa M; Sugimoto R; Mifuji-Moroka R; Hara N; Yoshikawa K; Tanaka H; Eguchi A; Yamamoto N; Sugimoto K; Kobayashi Y; Hasegawa H; Takei Y
    Metab Brain Dis; 2016 Oct; 31(5):1151-6. PubMed ID: 27353278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Covert hepatic encephalopathy: elevated total glutathione and absence of brain water content changes.
    Oeltzschner G; Butz M; Wickrath F; Wittsack HJ; Schnitzler A
    Metab Brain Dis; 2016 Jun; 31(3):517-27. PubMed ID: 26563124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lowered frequency and impaired modulation of gamma band oscillations in a bimodal attention task are associated with reduced critical flicker frequency.
    Kahlbrock N; Butz M; May ES; Brenner M; Kircheis G; Häussinger D; Schnitzler A
    Neuroimage; 2012 May; 61(1):216-27. PubMed ID: 22405731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluating a Novel, Portable, Self-Administrable Device ("Beacon") That Measures Critical Flicker Frequency as a Test for Hepatic Encephalopathy.
    Vutien P; Li R; Karkar R; Munson SA; Fogarty J; Walter K; Yacoub M; Ioannou GN
    Am J Gastroenterol; 2023 Jun; 118(6):1096-1100. PubMed ID: 36746413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
    Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate.
    Strebel H; Haller B; Sohn M; Schepp W; Gundling F
    GE Port J Gastroenterol; 2020 Nov; 27(6):391-403. PubMed ID: 33251288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.
    Ndraha S; Simadibrata M
    Acta Med Indones; 2010 Jul; 42(3):158-61. PubMed ID: 20724770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis.
    Gundling F; Schmidtler F; Hapfelmeier A; Schulte B; Schmidt T; Pehl C; Schepp W; Seidl H
    Liver Int; 2011 Oct; 31(9):1406-15. PubMed ID: 22093455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.